Mizuho Increases Acadia Healthcare Company, Inc. (ACHC) Price Target to $60.00
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) had its price target boosted by equities researchers at Mizuho from $57.00 to $60.00 in a research note issued on Friday. The brokerage currently has a “buy” rating on the stock. Mizuho’s price objective indicates a potential upside of 21.88% from the stock’s previous close.
ACHC has been the topic of a number of other reports. William Blair started coverage on shares of Acadia Healthcare in a research report on Tuesday, July 18th. They issued an “outperform” rating on the stock. Deutsche Bank AG assumed coverage on shares of Acadia Healthcare in a research note on Wednesday, April 5th. They set a “buy” rating and a $53.00 target price on the stock. Zacks Investment Research upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Friday, April 28th. Jefferies Group LLC set a $55.00 price objective on shares of Acadia Healthcare and gave the stock a “buy” rating in a research note on Thursday, June 1st. Finally, Leerink Swann cut shares of Acadia Healthcare from an “outperform” rating to a “market perform” rating in a research note on Monday, May 15th. Three analysts have rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $57.85.
Acadia Healthcare (NASDAQ:ACHC) traded up 7.78% during midday trading on Friday, reaching $53.06. 1,241,043 shares of the company’s stock were exchanged. The firm has a 50-day moving average price of $48.22 and a 200 day moving average price of $43.60. Acadia Healthcare has a 12-month low of $32.54 and a 12-month high of $57.29. The company has a market cap of $4.66 billion, a price-to-earnings ratio of 308.49 and a beta of 1.14.
Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. The business had revenue of $715.90 million for the quarter, compared to the consensus estimate of $717.38 million. Acadia Healthcare had a net margin of 0.53% and a return on equity of 8.89%. The company’s quarterly revenue was down 5.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.73 EPS. On average, analysts expect that Acadia Healthcare will post $2.44 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This piece was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/07/28/mizuho-increases-acadia-healthcare-company-inc-achc-price-target-to-60-00.html.
In related news, VP Randall P. Goldberg sold 4,925 shares of the business’s stock in a transaction that occurred on Thursday, May 4th. The stock was sold at an average price of $45.18, for a total transaction of $222,511.50. Following the completion of the sale, the vice president now directly owns 10,607 shares in the company, valued at $479,224.26. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Ronald Morgan Fincher sold 86,483 shares of the business’s stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $44.43, for a total value of $3,842,439.69. Following the sale, the chief operating officer now owns 137,204 shares of the company’s stock, valued at $6,095,973.72. The disclosure for this sale can be found here. Insiders have sold 968,102 shares of company stock valued at $44,283,109 over the last quarter. 11.10% of the stock is owned by company insiders.
Hedge funds have recently modified their holdings of the stock. Jennison Associates boosted its stake in shares of Acadia Healthcare by 13.2% in the third quarter. Jennison Associates now owns 914,130 shares of the company’s stock valued at $60,579,000 after buying an additional 106,711 shares during the last quarter. Eagle Asset Management boosted its position in Acadia Healthcare by 71.3% in the third quarter. Eagle Asset Management now owns 2,097,614 shares of the company’s stock worth $139,008,000 after buying an additional 872,995 shares in the last quarter. Janus Capital Management acquired a new position in Acadia Healthcare during the third quarter worth $4,095,000. Manning & Napier Advisors acquired a new position in Acadia Healthcare during the fourth quarter worth $10,107,000. Finally, Three Peaks Capital Management acquired a new position in Acadia Healthcare during the fourth quarter worth $2,547,000.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.